Dr Joanna Kirman

Immunologist
Microbiology & Immunology
Otago University
New Zealand

Biography

BSc (Hons), University of Otago (1996) PhD (Pathology), University of Otago (1999), Infectious Diseases Group Leader, Malaghan Institute of Medical Research, Wellington (2002-2012)

Research Intrest

Applied, cellular and molecular immunology, medical microbiology, vaccine immunology and technology.

List of Publications

Sustained in vivo depletion of splenic langerin+ CD8alpha+ dendritic cells is well-tolerated by lang-DTREGFP mice Prendergast KA, Osmond, TL, Ochiai S, Hermans IF, Kirman JR J Immunological Methods (2014) 406:104-

IL-1Î²R-dependent priming of antitumor CD4+ T cells and sustained antitumor immunity after peri-tumoral treatment with MSU and mycobacteria. Kuhn, S., Yang, J., Hyde, E. J., Harper, J. L., Kirman, J. R., & Ronchese, F. (2015). OncoImmunology, 4(10), e1042199.

Find Experts

Experts in Immunology

Dr Joanna Kirman

Sustained in vivo depletion of splenic langerin+ CD8alpha+ dendritic cells is well-tolerated by lang-DTREGFP mice Prendergast KA, Osmond, TL, Ochiai S, Hermans IF, Kirman JR J Immunological Methods (2014) 406:104-

IL-1Î²R-dependent priming of antitumor CD4+ T cells and sustained antitumor immunity after peri-tumoral treatment with MSU and mycobacteria. Kuhn, S., Yang, J., Hyde, E. J., Harper, J. L., Kirman, J. R., & Ronchese, F. (2015). OncoImmunology, 4(10), e1042199.

The Memory Immune Response to Tuberculosis. Kirman JR, Henao-Tamayo MI, Agger EM. Microbiol Spectr. (2016) Dec;4(6).

Experts in New Zealand

Connect with your Global Scientific Fields by Subject